Michael Faibish
Impact in
-
- Invertebrate Immune Response Mechanisms
- Galectins and Cancer Biology
- Genetics top 10%
- Glioma Diagnosis and Treatment
Papers in ⓘ
-
- Angiogenesis and VEGF in Cancer 4
- Studies on Chitinases and Chitosanases 3
- Microbial metabolism and enzyme function 2
- Kruppel-like factors research 1
- Oncology 7
- Cancer Cells and Metastasis 4
- Peptidase Inhibition and Analysis 3
- Co-authors
- Ralph Francescone (7 shared papers)Brooke Bentley (5 shared papers)Rong Shao (4 shared papers)Wei Yan (3 shared papers)Rong Shao (2 shared papers)Sherry L. Taylor (3 shared papers)Steve Scully (3 shared papers)Luis Moral (3 shared papers)
- Journals
- Journal of Visualized Experiments (2 papers)Cancer Research (2 papers)Molecular Cancer Therapeutics (1 paper)Journal of Neuroscience (1 paper)Journal of Biological Chemistry (1 paper)
- Partner nations
- United States
In The Last Decade
Michael Faibish
10 papers receiving 691 citations
Peers
Comparison fields: 5 of 79
- Immunology 187
- Genetics 93
- Cancer Research 124
- Oncology 220
- Molecular Biology 532
Countries citing papers authored by Michael Faibish
This map shows the geographic impact of Michael Faibish's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Faibish with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Faibish more than expected).
Fields of papers citing papers by Michael Faibish
This network shows the impact of papers produced by Michael Faibish. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Faibish. The network helps show where Michael Faibish may publish in the future.
Co-authors
The 17 scholars most cited alongside Michael Faibish, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 218 | |
| 2 | 2011 | 151 | |
| 3 | 2012 | 135 | |
| 4 | 2011 | 101 | |
| 5 | 2013 | 43 | |
| 6 | 2014 | 21 | |
| 7 | 2011 | 17 | |
| 8 | 2013 | 12 | |
| 9 | 2012 | 2 | |
| 10 | 2012 | 1 |
About Michael Faibish
Michael Faibish is a scholar working on Molecular Biology, Oncology, Immunology, Cancer Research and Genetics, having authored 10 papers that have together received 701 indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (4 papers), Cancer Cells and Metastasis (4 papers), Studies on Chitinases and Chitosanases (3 papers), Peptidase Inhibition and Analysis (3 papers), Galectins and Cancer Biology (2 papers), Microbial metabolism and enzyme function (2 papers), Invertebrate Immune Response Mechanisms (1 paper) and Kruppel-like factors research (1 paper). The work is most often cited by research in Immunology (187 citations), Genetics (93 citations), Cancer Research (124 citations), Oncology (220 citations) and Molecular Biology (532 citations). Michael Faibish has collaborated with scholars based in United States. Frequent co-authors include Ralph Francescone, Brooke Bentley, Rong Shao, Wei Yan, Rong Shao, Sherry L. Taylor, Steve Scully, Luis Moral, Dennis Oh and Philip C. Trackman. Their work appears in journals such as Journal of Visualized Experiments, Cancer Research, Molecular Cancer Therapeutics, Journal of Neuroscience and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.